Correlation between macular volume and focal macular electroretinogram in patients with retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 8, 2008, Pages 3551-3558

  Sugita, Tadasu ^a   Kondo, Mineo ^a   Piao, Chang Hua ^a   Ito, Yasuki ^a   Terasaki, Hiroko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

A WAVE; ADOLESCENT; ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; B WAVE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FEMALE; FOCAL MACULA ELECTRORETINOGRAPHY; HUMAN; IMAGE ANALYSIS; MALE; OPTICAL COHERENCE TOMOGRAPHY; ORGAN SIZE; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA MACULA LUTEA; RETINA NEUROEPITHELIAL LAYER; RETINA ROD OUTER SEGMENT; RETINITIS PIGMENTOSA; TISSUE STRUCTURE; VISUAL STIMULATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; PHOTORECEPTORS, VERTEBRATE; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 49049120544     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1954     Document Type: Article

References (52)

1. Carr RE, Heckenlively JR. Hereditary pigmentary degenerations of the retina. In: Duane TD, Jaeger EA, eds. Clinical Ophthalmology. Philadelphia: JB Lippincott; 1987;1-28.
2. Heckenlively JR. RP syndromes. In: Heckenlively JR, ed. Retinitis Pigmentosa. Philadelphia: JB Lippincott; 1988;221-252.
3. Newsome DA. Retinitis pigmentosa, Usher's syndrome, and other pigmentary retinopathies. In: Newsome DA, ed. Retinal Dystrophies and Degenerations. New York: Raven Press; 1988;161-194.
4. Weleber RG, Gregory-Evance K. Retinitis pigmentosa and allied disorders. In: Hinton DR, ed. Retina. 4th ed. Vol. 1. Basic science and inherited retinal disease. St. Louis: Mosby; 2006;395-498.
5. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-1809.
6. Szamier RB, Berson EL, Klein R, Meyers S. Sex-linked retinitis pigmentosa: ultrastructure of photoreceptors and pigment epithelium. Invest Ophthalmol Vis Sci. 1979;18:145-160.
7. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;175-205.
8. Fariss RN, Li ZY, Milam AH. Abnormalities in rod photoreceptors, amacrine cells, and horizontal cells in human retinas with retinitis pigmentosa. Am J Ophthalmol. 2000;129:215-223.
9. Sandberg MA, Effron MH, Berson EL. Focal cone electroretinograms in dominant retinitis pigmentosa with reduced penetrance. Invest Ophthalmol Vis Sci. 1978;17:1096-1101.
10. Biersdorf WR. Temporal factors in the foveal ERG. Curr Eye Res. 1982;1:717-722.
11. Seiple W, Siegel IM, Carr RE, Mayron C. Evaluating macular function using the focal ERG. Invest Ophthalmol Vis Sci. 1986;27:1123-1130.
12. Falsini B, Iarossi G, Porciatti V, et al. Postreceptoral contribution to macular dysfunction in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1994;35:4282-4290.
13. Ikenoya K, Kondo M, Piao CH, et al. Preservation of macular oscillatory potentials in eyes of patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2007;48:3312-3317.
14. Hood DC, Holopigian K, Greenstein V, et al. Assessment of local retinal function in patients with retinitis pigmentosa using the multi-focal ERG technique. Vision Res. 1998;38:163-179.
15. Chan HL, Brown B. Investigation of retinitis pigmentosa using the multifocal electroretinogram. Ophthalmic Physiol Opt. 1998;18:335-350.
16. Seeliger MW, Kretschmann UH, Apfelstedt-Sylla E, Zrenner E. Implicit time topography of multifocal electroretinograms. Invest Ophthalmol Vis Sci. 1998;39:718-723.
17. Felius J, Swanson WH. Photopic temporal processing in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1999;40:2932-2944.
18. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000;19:607-646.
19. Holopigian K, Seiple W, Greenstein VC, et al. Local cone and rod system function in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2001;42:779-788.
20. Vajaranant TS, Seiple W, Szlyk JP, Fishman GA. Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology. 2002;109:560-568.
21. Robson AG, Saihan Z, Jenkins SA, et al. Functional characterization and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol. 2006;90:472-479.
22. Jacobson SG, Buraczynska M, Milam AH, et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Invest Ophthalmol Vis Sci. 1997;38:1983-1997.
23. Jacobson SG, Cideciyan AV, Huang Y, et al. Retinal degenerations with truncation mutations in the cone-rod homeobox (CRX) gene. Invest Ophthalmol Vis Sci. 1998;39:2417-2426.
24. Jacobson SG, Cideciyan AV, Iannaccone A, et al. Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000;41:1898-1908.
25. Schatz P, Abrahamson M, Eksandh L, Ponjavic V, Andréasson S. Macular appearance by means of OCT and electrophysiology in members of two families with different mutations in RDS (the peripherin/RDS gene). Acta Ophthalmol Scand. 2003;81:500-507.
26. Jacobson SG, Cideciyan AV, Aleman TS, et al. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum Mol Genet. 2003;12:1073-1078.
27. Sandberg MA, Brockhurst RJ, Gaudio AR, Berson EL. The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2005;46:3349-3354.
28. Schwartz SB, Aleman TS, Cideciyan AV, et al. Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype. Invest Ophthalmol Vis Sci. 2005;46:734-743.
29. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2006;102:6177-6182.
30. Witkin AJ, Ko TH, Fujimoto JG, et al. Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. Am J Ophthalmol. 2006;142:945-952.
31. Cideciyan AV, Aleman TS, Jacobson SG, et al. Centrosomal-ciliary gene CEP290/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis. Hum Mutat. 2007;28:1074-1083.
32. Jacobson SG, Cideciyan AV, Aleman TS, et al. Leber congenital amaurosis caused by an RPGRIP1 mutation shows treatment potential. Ophthalmology. 2007;114:895-898.
33. Aleman TS, Cideciyan AV, Sumaroka A, et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Invest Ophthalmol Vis Sci. 2007;48:4759-4765.
34. Apushkin MA, Fishman GA, Alexander KR, Shahidi M. Retinal thickness and visual thresholds measured in patients with retinitis pigmentosa. Retina. 2007;27:349-357.
35. Walia S, Fishman GA, Edward DP, Lindeman M. Retinal nerve fiber layer defects in RP patients. Invest Ophthalmol Vis Sci. 2007;8:4748-4752.
36. Matsuo T, Morimoto N. Visual acuity and perimacular retinal layers detected by optical coherence tomography in patients with retinitis pigmentosa. Br J Ophthalmol. 2007;91:888-9033.
37. Horio N, Kachi S, Hori K, et al. Progressive change of optical coherence tomography scans in retinal degeneration slow mice. Arch Ophthalmol. 2001;119:1329-1332.
38. Li Q, Timmers AM, Hunter K, et al. Noninvasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse. Invest Ophthalmol Vis Sci. 2001;42:2981-2989.
39. Huang Y, Cideciyan AV, Papastergiou GI, et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39:2405-2416.
40. Huang Y, Cideciyan AV, Alemán TS, et al. Optical coherence tomography (OCT) abnormalities in rhodopsin mutant transgenic swine with retinal degeneration. Exp Eye Res. 2000;70:247-251.
41. Marmor MF, Holder GE, Seeliger MW, Yamamoto S; International Society for Clinical Electrophysiology of Vision. Standard for clinical electroretinography (2004 update). Doc Ophthalmol. 2004;108:107-114.
42. Miyake Y, Shiroyama N, Ota I, Horiguchi M. Oscillatory potentials in electroretinograms of the human macular region. Invest Ophthalmol Vis Sci. 1988;29:1631-1635.
43. Miyake Y. Studies of local macular ERG (in Japanese). Acta Soc Ophthalmol Jpn. 1988;92:1418-1449.
44. Wong TY, Foster PJ, Ng TP, et al. Variations in ocular biometry in an adult Chinese population in Singapore: the Tanjong Pagar Survey. Invest Ophthalmol Vis Sci. 2001;42:73-80.
45. Shufelt C, Fraser-Bell S, Ying-Lai M, et al. Refractive error, ocular biometry, and lens opalescence in an adult population: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2005;46:4450-4460.
46. Olsen T, Arnarsson A, Sasaki H, et al. On the ocular refractive components: the Reykjavik Eye Study. Acta Ophthalmol Scand. 2007;85:361-366.
47. Costa RA, Calucci D, Skaf M, et al. Optical coherence tomography 3: Automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci. 2004;45:2399-2406.
48. Ishikawa K, Kondo M, Ito Y, et al. Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy. Invest Ophthalmol Vis Sci. 2007;48:2254-2259.
49. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003;121:695-706.
50. Costa RA, Skaf M, Melo LA Jr, et al. Retinal assessment using optical coherence tomography. Prog Retin Eye Res. 2006;25:325-353.
51. Pons ME, and Garcia-Valenzuela E. Redefining the limit of the outer retina in optical coherence tomography scans. Ophthalmology. 2005;112:1079-1085.
52. Machida S, Kondo M, Jamison JA, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 2000;41:3200-3209.